Slika na naslovnici

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma

Purpose:To investigate the survival outcomes and toxicities associated with the addition of nimotuzumab to concurrent chemoradiotherapy (CCRT) in locally advanced nasopharyngeal carcinoma (LANPC) patients who received induction chemotherapy (IC).Methods:Patients with stage III-IVA nasopharyngeal car...

Shranjeno v:

Bibliografske podrobnosti
Main Authors:	Run-Jie Wang (Author), Rui-Quan Ke (Author), Yi-Feng Yu (Author), Guan-Zhong Lu (Author), San-Gang Wu (Author)
Format:	Knjiga
Izdano:	Frontiers Media S.A., 2024-03-01T00:00:00Z.
Teme:	article
Online dostop:	Connect to this object online.
Oznake:	Označite Brez oznak, prvi označite!

Podobne knjige/članki

Changes in T lymphocyte subsets in peripheral blood of patients with middle-advanced cervical cancer before and after nimotuzumab combined with concurrent chemoradiotherapy
od: Man Ao, et al.
Izdano: (2023)

The Outcome of Induction Chemotherapy, Followed by Neoadjuvant Chemoradiotherapy and Surgery, in Locally Advanced Rectal Cancer
od: Ali Yaghobi Joybari, et al.
Izdano: (2021)

Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
od: Huang JF, et al.
Izdano: (2018)

The predictive value of pretreatment hemoglobin-to-platelet ratio on osteoradionecrosis incidence rates of locally advanced nasopharyngeal cancer patients managed with concurrent chemoradiotherapy
od: Busra Yilmaz, et al.
Izdano: (2023)

Outcomes of Adding Induction Chemotherapy to Concurrent Chemotherapy for Nasopharyngeal Carcinoma Patients with Moderate-Risk in the Intensity-Modulated Radiotherapy Era
od: Su Z, et al.
Izdano: (2020)

Assessment of Response to Different Induction Chemotherapy Regimens in Locally Advanced Nasopharyngeal Carcinoma
od: Lian CL, et al.
Izdano: (2023)

Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study
od: Jingjing Miao, et al.
Izdano: (2023)

Investigation on the Efficiency of Chinese Herbal Injections combined with Concurrent Chemoradiotherapy for Treating Nasopharyngeal Carcinoma based on Multidimensional Bayesian Network Meta-analysis
od: Zhishan Wu, et al.
Izdano: (2021)

Concurrent chemoradiotherapy with S-1 versus platinum in the treatment of locoregionally advanced nasopharyngeal carcinoma: a multicenter, retrospective, propensity score-matched analysis
od: Chenbin Bian, et al.
Izdano: (2024)

Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
od: Seyed Amir Aledavood, et al.
Izdano: (2021)

Explore the Usefulness of Concurrent Chemotherapy in Stage II Nasopharyngeal Carcinoma: A Retrospective Study
od: Pei-Jing Li, et al.
Izdano: (2021)

High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
od: Haksoyler V, et al.
Izdano: (2021)

Secondary uterine carcinosarcoma after concurrent chemoradiotherapy for cervical cancer: Case reports
od: Akihiko Wakayama, et al.
Izdano: (2017)

Use CT Imaging to Predict the Short-Term Outcome of Concurrent Chemoradiotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
od: Xiaolan Cao, et al.
Izdano: (2019)

The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy
od: Topkan E, et al.
Izdano: (2021)

Comparisons of survivals and toxicities between young and elderly patients with cervical cancer treated with definitive radiotherapy or concurrent chemoradiotherapy
od: Weiping Wang, et al.
Izdano: (2019)

LncRNAs Associated with Chemoradiotherapy Response and Prognosis in Locally Advanced Rectal Cancer
od: Zhang Y, et al.
Izdano: (2021)

Adverse events to the nimotuzumab in patients with primary cerebral tumor
od: Yasley Gámez Fernández, et al.
Izdano: (2022)

Radiation-Induced Uterine Carcinosarcoma after Concurrent Chemoradiotherapy for Cervical Squamous Cell Carcinoma
od: Joana Moreira-Barros, et al.
Izdano: (2018)

Spontaneous ureteral rupture during concurrent chemoradiotherapy in a woman with uterine cervical cancer
od: Shun-ichi Ikeda, et al.
Izdano: (2015)

Role of chemotherapy in nasopharyngeal carcinoma
od: Fabiola Paiar, et al.
Izdano: (2012)

Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
od: Yilmaz B, et al.
Izdano: (2021)

Humoral characteristics of head and neck tumors in patients treated with nimotuzumab
od: Lisandra Roca Serra, et al.
Izdano: (2018)

Plasma free fatty acid levels in cervical cancer: concurrent chemoradiotherapy improves abnormal profile
od: Xiaoying Xu, et al.
Izdano: (2024)

Prognostic and Predictive Value of Circulating Inflammation Signature in Non-Metastatic Nasopharyngeal Carcinoma: Potential Role for Individualized Induction Chemotherapy
od: Lv SH, et al.
Izdano: (2021)

Safety of nimotuzumab following clinical trials in head and neck epithelial tumors
od: Oneyda Clapé-Laffita, et al.
Izdano: (2021)

Hemorrhage During Induction Chemotherapy in Neuroblastoma: Additional Risk Factors in High-Risk Patients
od: Valerio Voglino, et al.
Izdano: (2021)

Concurrent occurrence of nasopharyngeal and disseminated cutaneous rhinosporidiosis: A rare presentation
od: Subhamoy Neogi, et al.
Izdano: (2023)

Predictors of Quality of Life Change in Head-and-Neck Cancer Survivors during Concurrent Chemoradiotherapy: A Prospective Study
od: Ya-Hui Tsan, et al.
Izdano: (2021)

Overexpression of Dehydrogenase/Reductase 9 Predicts Poor Response to Concurrent Chemoradiotherapy and Poor Prognosis in Rectal Cancer Patients
od: Tzu-Ju Chen, et al.
Izdano: (2022)

Paclitaxel liposome, cisplatin and 5-fluorouracil-based induction chemotherapy followed by de-escalated intensity-modulated radiotherapy with concurrent cisplatin in stage IVA-IVB childhood nasopharyngeal carcinoma in endemic area: a phase II, single-arm trialResearch in context
od: Dong-Hua Luo, et al.
Izdano: (2023)

Transdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life
od: Guo SP, et al.
Izdano: (2014)

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab
od: Greta Garrido, et al.
Izdano: (2017)

Use of patient‐derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
od: Weisong Xue, et al.
Izdano: (2023)

Local Therapy of Acute Nasopharyngitis in Children
od: Ye.I. Yulish, et al.
Izdano: (2013)

Endoscopic Submucosal Dissection Followed by Concurrent Chemoradiotherapy in Patients with Early Esophageal Cancer with a High Risk of Lymph Node Metastasis
od: Hee Kyung Kim, et al.
Izdano: (2019)

Complete remission in very advanced oral cancer by docetaxel, cisplatin, 5-fluorouracil based induction chemotherapy followed by concurrent chemoradiation
od: Tien-En Chiang, et al.
Izdano: (2018)

Is it Possible to Successfully Treat Locally Advanced Colon Cancer Using Pre-Operative Chemoradiotherapy?
od: Ji Hun Choi, et al.
Izdano: (2019)

The value of plasma omega-3 polyunsaturated fatty acids in predicting the response and prognosis of cervical squamous cell carcinoma patients to concurrent chemoradiotherapy
od: Pengbin Ping, et al.
Izdano: (2024)

Graphene quantum dots‐based targeted nanoprobes detecting drug delivery, imaging, and enhanced chemotherapy of nasopharyngeal carcinoma
od: Chaosheng Yu, et al.
Izdano: (2022)